BROADCASTS.com

This week, the top managed care stories included the Trump administration proposed extending the duration of short-term health plans; a report found that CAR T-cell therapies are worth their high price tags; the new issue of\xa0Evidence-Based Oncology\xae examined current issues in immunotherapy.\n\nRead more about the stories in this podcast:\nTrump Administration Proposes Extending Short-Term Health Plans to 12 Months: www.ajmc.com/newsroom/trump-administration-proposes-extending-shortterm-health-plans-to-12-months\n\nWhat We're Reading: Cost of Healthcare Bills; Albertsons Buying Rite Aid; Pediatric Cancer Therapies: www.ajmc.com/newsroom/what-were-reading-cost-of-healthcare-bills-albertsons-buying-rite-aid-pediatric-cancer-therapies\n\nICER Report: Costs of Approved CAR T-Cell Therapies Aligned With Clinical Benefit: www.ajmc.com/newsroom/icer-report-costs-of-approved-car-tcell-therapies-aligned-with-clinical-benefit\n\nEvidence-Based Oncology\xae \u2013 February 2018: www.ajmc.com/journals/evidence-based-oncology/2018/february-2018